4.6 Article

Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Geriatrics & Gerontology

Plasma Total α-Synuclein and Neurofilament Light Chain: Clinical Validation for Discriminating Parkinson's Disease from Normal Control

Wei-Che Lin et al.

Summary: This study validated the use of plasma total alpha-synuclein to distinguish Parkinson's disease patients from normal controls, and also observed an elevation in plasma neurofilament light chain levels in Parkinson's disease patients.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2021)

Article Geriatrics & Gerontology

Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction

Pai-Yi Chiu et al.

Summary: By utilizing a composite scale consisting of MDQ and DAT imaging, it can aid in detecting DLB easily in healthcare settings without movement disorder specialists. The study findings also indicate that the composite scale significantly improves the diagnostic accuracy compared to using MDQ or SBR alone.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Neurosciences

An Informant-Based Simple Questionnaire for Visuospatial Dysfunction Assessment in Dementia

Ching-Tsu Wang et al.

FRONTIERS IN NEUROSCIENCE (2020)

Article Engineering, Biomedical

Analyze Informant-Based Questionnaire for The Early Diagnosis of Senile Dementia Using Deep Learning

Fubao Zhu et al.

IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE (2020)

Article Clinical Neurology

Plasma α-synuclein predicts cognitive decline in Parkinson's disease

Chin-Hsien Lin et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)

Article Geriatrics & Gerontology

Decreased alpha-Synuclein Serum Levels in Patients with Lewy Body Dementia Compared to Alzheimer's Disease Patients and Control Subjects

Christoph Laske et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)

Article Clinical Neurology

Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease

Kensaku Kasuga et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Article Neurosciences

CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease

Moeko Noguchi-Shinohara et al.

BRAIN RESEARCH (2009)

Article Neurosciences

Cerebrospinal Fluid alpha-Synuclein Does Not Discriminate Between Dementia Disorders

Petra E. Spies et al.

JOURNAL OF ALZHEIMERS DISEASE (2009)

Article Neurosciences

Cerebrospinal fluid α-synuclein in neurodegenerative disorders-A marker of synapse loss?

Annika Ohrfelt et al.

NEUROSCIENCE LETTERS (2009)

Article Clinical Neurology

Red blood cells are the major source of alpha-synuclein in blood

Robin Barbour et al.

NEURODEGENERATIVE DISEASES (2008)

Article Neurosciences

Plasma α-synuclein is decreased in subjects with Parkinson's disease

Qiao-Xin Li et al.

EXPERIMENTAL NEUROLOGY (2007)

Article Clinical Neurology

How to diagnose dementia with Lewy bodies: State of the art

F Geser et al.

MOVEMENT DISORDERS (2005)

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)